Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response
Crossref DOI link: https://doi.org/10.1186/s12885-015-1334-6
Published Online: 2015-05-12
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yeo, Winnie
Chan, Stephen L
Mo, Frankie KF
Chu, Cheuk M
Hui, Joyce WY
Tong, Joanne HM
Chan, Anthony WH
Koh, Jane
Hui, Edwin P
Loong, Herbert
Lee, Kirsty
Li, Leung
Ma, Brigette
To, Ka F
Yu, Simon CH
License valid from 2015-05-12